A 9-year-old girl presented with persistent labial fusion for pediatric surgical evaluation. On examination, she was noted to have bilateral undescended gonads.
Student Discussion Document (pdf)
Nilika Wijeratne,1,2,3* Alan R. McNeil,1 James C.G. Doery,2,3 Elizabeth McLeod,4 Philip B. Bergman,5,6 and
1Department of Biochemistry, Dorevitch Pathology, Heidelberg, Victoria, Australia; 2Monash Pathology, 3Department of Medicine, Monash University, 4Department of Pediatric Surgery, Monash Children’s, and 5Department of Pediatric Endocrinology and Diabetes, Monash Children’s, Monash Health, Clayton, Victoria, Australia, 6Department of Pediatrics, Monash University.
*Address correspondence to this author at: Dorevitch Pathology, 18 Banksia street, Heidelberg, Victoria 3084, Australia. E-mail [email protected]
A 9-year-old girl presented with persistent labial fusion for pediatric surgical evaluation. On examination, she was noted to have bilateral undescended gonads. A pelvic ultrasound was performed, which confirmed the testicular appearance of gonads and no visible uterus or Müllerian structures. She was referred to pediatric endocrinology.
She was born at term and was the second child of the family. She had no other significant medical problems. Her family history was unremarkable apart from her sister, who had mild, transient labial fusion. Her parents were not related.
The initial investigations revealed a 46, XY karyotype. The serum hormone results are shown in Table 1. After stimulation with 5000 U human chorionic gonadotropin (hCG),7 the testosterone concentration was 170 ng/dl (5.9 nmol/L), but the dihydrotestosterone (DHT) result was unavailable due to an analytical issue. A urine steroid profile (USP) was inconclusive with individual
analyte results within reference intervals (RIs). At this stage, the provisional diagnosis of complete androgen insensitivity syndrome (CAIS) was made and the endocrinologists opted to monitor the patient.
At 13 years of age, she went into puberty with pubic hair development, which led to further laboratory investigations (Table 1). USP revealed an increased etiocholanolone of 1.31 mg/day (4.5 μmol/day) [RI, <0.35 (<1.2)] and a low androsterone of 0.09 mg/day (0.3 μmol/day) [RI, <0.44 (<1.5)], resulting in extremely low 5α- to 5β-reduced steroid metabolites ratio of 0.06
(RI, 0.5–1.9). Pregnanediol, pregnanetriol, and cortisol metabolites concentrations were within reference ranges. The testosterone/DHT ratio was 12.6 (RI, <10) after hCG stimulation.
Questions to Consider
- How would you explain the differential diagnosis of an undervirilized genetic male?
- What tests could be used to investigate disorders of sex development?
- What is the most probable diagnosis in this patient?
Final Publication and Comments
The final published version with discussion and comments from the experts appears
in the June 2018 issue of Clinical Chemistry, approximately 3-4 weeks after the Student Discussion is posted.
If you are associated with an educational center and would like to receive the cases and
questions 3-4 weeks in advance of publication, please email [email protected].
AACC is pleased to allow free reproduction and distribution of this Clinical Case
Study for personal or classroom discussion use. When photocopying, please make sure
the DOI and copyright notice appear on each copy.
Copyright © 2018 American Association for Clinical Chemistry